Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-26 Sale |
2025-02-28 4:48 pm |
Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner |
194,628,820 | $0.0283 | $5,507,996 | 354,738 (Direct) |
View |
| 2023-12-21 Purchase |
2023-12-26 4:05 pm |
Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks |
1,886 | $3.315 | $6,252 | 35,264 (Direct) |
View |
| 2023-12-21 Purchase |
2023-12-26 4:05 pm |
Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO |
6,070 | $3.315 | $20,122 | 74,728 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 4:07 pm |
Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director |
12 | $3.5716 | $43 | 3,374 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Option Award |
2025-02-28 4:48 pm |
2025-02-26 2035-02-26 |
Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director |
700,000 | $0 | 700,000 (Direct) |
View |
| 2025-02-26 Exercise |
2025-02-28 4:48 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner |
197,374,082 | $0 | 354,738 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 4:47 pm |
2025-02-26 2035-02-26 |
Cyclacel Pharmaceuticals Inc. | CYCC | Ben-Tzvi Avraham Director |
700,000 | $0 | 700,000 (Direct) |
View |
Ownership |
2025-02-28 11:32 am |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Doris Wong Sing Ee Chief Executive Officer 10% Owner |
0 | $0 | 194,628,820 (Direct) |
View |
Ownership |
2025-02-28 11:31 am |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Chong Kwang Fock Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2025-02-28 11:31 am |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Kiu Cu Seng CFO and Secretary |
0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-10 5:45 pm |
2025-02-06 N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Interim CEO 10% Owner |
2,100,000 | $0 | 3,100,000 (Direct) |
View |
Ownership |
2025-01-08 5:25 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Ben-Tzvi Avraham Director |
0 | $0 | 0 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-07 7:07 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2025-01-07 7:06 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | NATAN DAVID Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2025-01-07 7:04 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Lazar David E. Chief Executive Officer |
0 | $0 | 2,650,000 (Direct) |
View |
| 2024-01-29 Option Award |
2024-01-31 4:56 pm |
N/A 2034-01-29 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Interim Chief Medical Officer |
12,500 | $0 | 27,705 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:58 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:57 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director |
63,657 | $0 | 82,853 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:57 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | Spiegel Robert J. Director |
63,657 | $0 | 81,853 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:57 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks |
70,200 | $0 | 70,200 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:56 pm |
2026-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer |
70,200 | $0 | 70,200 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:56 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | Walker Karin L Director |
63,657 | $0 | 83,040 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:56 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director |
63,657 | $0 | 87,390 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:55 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | HENNEY CHRISTOPHER S Director |
63,657 | $0 | 81,853 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:55 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
63,657 | $0 | 83,040 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:19 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks |
31,200 | $0 | 31,492 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:18 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO |
57,600 | $0 | 62,588 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:17 pm |
N/A N/A |
Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer |
31,200 | $0 | 31,200 (Direct) |
View |
| 2022-06-14 Option Award(A) |
2022-06-17 4:06 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director |
71,200 | $0 | 71,200 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:39 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | Ferguson Kenneth M. Director |
75,200 | $0 | 75,200 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:13 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | Walker Karin L Director |
47,467 | $0 | 51,028 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:12 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | Spiegel Robert J. Director |
47,467 | $0 | 49,841 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:11 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | Sems Lloyd Director |
47,467 | $0 | 49,841 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:11 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
47,467 | $0 | 51,028 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:11 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | HENNEY CHRISTOPHER S Director |
47,467 | $0 | 49,841 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:10 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | BARKER SAM L Director |
47,467 | $0 | 50,841 (Direct) |
View |
| 2021-12-13 Option Award(A) |
2021-12-16 4:16 pm |
N/A 2031-12-13 |
Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-15 4:20 pm |
N/A 2031-12-13 |
Cyclacel Pharmaceuticals Inc. | CYCC | Rombotis Spiro George President and CEO |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-15 4:19 pm |
N/A 2031-12-13 |
Cyclacel Pharmaceuticals Inc. | CYCC | McBarron Paul See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-15 4:18 pm |
N/A 2031-12-13 |
Cyclacel Pharmaceuticals Inc. | CYCC | Kirschbaum Mark Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |